IL6 and metabolic dysfunction-associated steatotic liver disease: Recently, it was discovered that when GPR35 was eliminated in the liver of non-alcoholic fatty liver disease (NAFLD) mice, there was an increase in inflammatory cytokines such as TNFα, IL6, and IL1β in the liver.